TP53 and colorectal carcinoma: Evolutionary studies of CRC have shown that TP53, APC, and KRAS mutations are the most dominant clonal mutations18, 19, 20; thus, it was hypothesized that there may be a correlation among the mutant allele frequencies of these genes in individual patients.